VNDA vs ARCT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ARCT Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) driven by superior Valuation, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Growth & Margin. Fundamentally, VNDA trades at 103.1x Forward P/E with -77.6% operating margin (+24.1% YoY revenue) versus ARCT at 2.5x Forward P/E and -311.2% operating margin (+6.7% YoY). In options structure, VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro) against ARCT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VNDA Revenue | ARCT Revenue | VNDA Op. Margin | ARCT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $190M | $20M | 11.3% | -138.5% | VNDA |
| FY2019 | $230M | $20M | 10.0% | -122.7% | VNDA |
| FY2020 | $250M | $10M | 11.0% | -749.8% | VNDA |
| FY2021 | $270M | $10M | 15.7% | -1641.3% | VNDA |
| FY2022 | $250M | $210M | 2.5% | 5.9% | ARCT |
| FY2023 | $190M | $170M | -7.2% | -46.9% | VNDA |
| FY2024 | $200M | $150M | -20.5% | -62.8% | VNDA |
| FY2025 | $220M | $80M | -70.0% | -93.0% | VNDA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VNDA | ARCT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.9M | $241.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 103.1x | 2.5x | Lower Multiple | ARCT |
| Forward P/E Ratio Valuation | 103.1x | 2.5x | Lower Multiple | ARCT |
| Revenue Growth (YoY) Growth | +24.1% | +6.7% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | -77.6% | -311.2% | Higher Margin | VNDA |
| Net Profit Margin Profitability | -119.9% | -285.9% | Higher Margin | VNDA |
| Return on Equity (ROE) Capital Efficiency | -82.5% | -44.4% | Higher ROE | ARCT |
| 52-Week Range Position Momentum | 4% ($4โ$10) | 24% ($6โ$18) | Stronger Trend | ARCT |
| Beta / 30D Volatility Risk Regime | 1.25ฮฒ ยท 61% Vol | 2.01ฮฒ ยท 127% Vol | Lower Realized Risk | VNDA |
| Unified Institutional Score Composite Signal | 49.0 / 100 (HOLD) | 57.7 / 100 (HOLD) | Higher Composite | ARCT |